BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 806345)

  • 21. Alternative forms of local treatment for burns.
    Lowbury EJ; Lilly HA; Cason JS; Jackson DM; Bull JP; Davies JW; Ford PM
    Lancet; 1971 Nov; 2(7734):1105-11. PubMed ID: 4107394
    [No Abstract]   [Full Text] [Related]  

  • 22. A laboratory method to evaluate formulation effects on the in vitro antimicrobial activity of topical creams and ointments.
    Love D; Kubey W; Holmes CJ
    Burns Incl Therm Inj; 1987 Jun; 13(3):204-7. PubMed ID: 3300889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical therapy of burns in children with silver sulfadiazine.
    Dickinson SJ
    N Y State J Med; 1973 Aug; 73(16):2045-9. PubMed ID: 4516608
    [No Abstract]   [Full Text] [Related]  

  • 24. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing.
    Robb EC; Nathan P
    J Trauma; 1981 Oct; 21(10):889-93. PubMed ID: 7277534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silver phosphanilamidopyrimidine. A new silver sulfadiazine analogue effective against Pseudomonas infection in burned mice.
    Wysor MS; Zollinhofer RE
    Chemotherapy; 1973; 18(6):342-7. PubMed ID: 4200356
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of supraeschar and subeschar Pseudomonas infection by silver sulfadiazine dry foam.
    Catania PN; King JC
    J Pharm Sci; 1975 Mar; 64(3):457-8. PubMed ID: 807702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns.
    Stanford W; Rappole BW; Fox CL
    J Trauma; 1969 May; 9(5):377-88. PubMed ID: 5771755
    [No Abstract]   [Full Text] [Related]  

  • 28. Delivery of the topical antimicrobial agents silver sulfadiazine, gentamicin and nystatin to infected burn wounds in rats from preloaded synthetic dressings.
    Robb EC; Fitz DG; Nathan P
    Trans Am Soc Artif Intern Organs; 1980; 26():533-6. PubMed ID: 6787772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Microbiological analysis of experimental burn wounds in swine during treatment with silver sulfadiazine].
    Denys A; Grzybowski A; Białek J; Horoszewicz-Małafiej A; Korczak E; Kowalska M; Małafiej E; Szydłowska T
    Med Dosw Mikrobiol; 1983; 35(2):155-62. PubMed ID: 6423917
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of a new topical agent for burn therapy. Silver sulfadiazine (silvadene).
    Ballin JC
    JAMA; 1974 Nov; 230(8):1184-5. PubMed ID: 4479596
    [No Abstract]   [Full Text] [Related]  

  • 31. Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections.
    Modak S; Fox CL
    J Trauma; 1985 Jan; 25(1):27-31. PubMed ID: 3917512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of topical povidone-iodine ointment in experimental burn wound sepsis.
    Robson MC; Schaerf RH; Krizek TJ
    Plast Reconstr Surg; 1974 Sep; 54(3):328-34. PubMed ID: 4211994
    [No Abstract]   [Full Text] [Related]  

  • 33. Silver nylon cloth: in vitro and in vivo evaluation of antimicrobial activity.
    Deitch EA; Marino AA; Malakanok V; Albright JA
    J Trauma; 1987 Mar; 27(3):301-4. PubMed ID: 3560272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [An experimental validation of the use of levomycetin preparations for the treatment of burns infected with Pseudomonas aeruginosa].
    Tkachenko VL; Tsyganenko AIa; Liapunov NA; Bezuglaia EP; Minukhin VV
    Mikrobiol Z; 1999; 61(3):30-6. PubMed ID: 10483230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burns and the use of silver sulphadiazine.
    McDougall IA
    Aust N Z J Surg; 1972 Nov; 42(2):174-8. PubMed ID: 4218758
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacology and clinical use of silver sulfadiazine and related topical antimicrobial agents.
    Fox CL
    Pahlavi Med J; 1977 Jan; 8(1):45-64. PubMed ID: 834468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orally-administered silver sulfadiazine: chemotherapy and toxicology in CF-1 mice; Plasmodium berghei (Malaria) and Pseudomonas aeruginosa.
    Wysor MS
    Chemotherapy; 1975; 21(5):302-10. PubMed ID: 807459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental animal studies of the healing of burn wounds with the use of local antimicrobials and hyperbaric O2 therapy].
    Kaiser W
    Z Exp Chir Transplant Kunstliche Organe; 1989; 22(1):27-37. PubMed ID: 2711716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silver sulfadiazine (AgSD) resistant pseudomonas infection in experimental burn wounds.
    Modak SM; Stanford JW; Bradshaw W; Fox CL
    Panminerva Med; 1983; 25(3):181-8. PubMed ID: 6669393
    [No Abstract]   [Full Text] [Related]  

  • 40. Combined use of topical cyclosporin A and silver sulphadiazine on allografts infected with Pseudomonas in burned rats.
    Lai CS; Miskell P; Gonce SJ; Alexander JW; Babcock GF
    Burns Incl Therm Inj; 1987 Jun; 13(3):181-4. PubMed ID: 3111646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.